Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

How to Identify Drugs that Work Best for Each Patient

April 24, 2015 11:53 am | by Anne Trafton, MIT News | News | Comments

Implantable device could allow doctors to test cancer drugs in patients before prescribing chemotherapy. Read more...

TOPICS:

Hope for an Effective Malaria Therapy with Just One Tablet

April 24, 2015 8:54 am | by Medical University of Vienna | News | Comments

Approximately 584,000 people worldwide die of malaria each year. Read more...

TOPICS:

Manchester Joins European Consortium to Develop Liquid Biopsies

April 24, 2015 8:47 am | by University of Manchester | News | Comments

An international project to validate blood-based biomarkers for cancer has added a new member. Read more...

TOPICS:
Advertisement

New Gel Medication Delays Release of Drug to Benefit Patients

April 24, 2015 8:38 am | by University of Huddersfield | News | Comments

Gellan gum pharmaceutical development both delays drug release for maximum effect and can be administered as fluid to aid those who have difficulty swallowing pills. Read more....

TOPICS:

Protein Links Point to Future Alzheimer's Treatments

April 24, 2015 8:29 am | by University of Cambridge | News | Comments

Researchers have identified how proteins that play a key role in Alzheimer’s disease are linked in a pathway that controls its progression. Read more....

TOPICS:

Wellness Advocate, Bestselling Author: I Faked Cancer

April 24, 2015 8:21 am | by Seth Augenstein, Digital Reporter | Articles | Comments

A woman who became a bestselling author and wellness advocate after she claimed she healed herself of a brain tumor through a healthy diet recently admitted she never had cancer. Read more...

TOPICS:

FDA Grants Priority Review for Boehringer Ingelheim's Idarucizumab

April 23, 2015 2:06 pm | News | Comments

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the Biologics License Application (BLA) for idarucizumab. Read more...

TOPICS:

FDA Accepts Filing of Bayer's MS Treatment

April 23, 2015 2:03 pm | News | Comments

Bayer is pleased to announce today that the U.S. Food and Drug Administration (FDA) has accepted the filing for Bayer's supplemental Biologics License Application (sBLA) for Betaconnect (proposed name), another delivery option for Betaseron (interferon beta-1b), a treatment for relapsing-remitting multiple sclerosis. 

TOPICS:
Advertisement

Finding Points to a Cause of Chronic Lung Disease

April 23, 2015 1:58 pm | by Washington University in St. Louis | News | Comments

Scientists have long suspected that respiratory viruses — the sort that cause common colds or bronchitis — play a critical role in the long-term development of chronic lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). Read more...

TOPICS:

Majority of Lung Cancer Treatment Decisions Not Guided by Genetics: Survey

April 23, 2015 1:47 pm | News | Comments

Despite the majority of newly diagnosed advanced non-small cell lung cancer (NSCLC) patients being tested for genetic mutations, a gap still exists for providing a personalized treatment plan for patients based on their cancer type and mutation subtype, according to a new international survey. Read more...

TOPICS:

CDC Using New Technology to Track Listeria Illnesses

April 23, 2015 1:41 pm | by Mary Clare Jalonick, Associated Press | News | Comments

The government is relying on some new technology - as well as a bit of luck - to track an outbreak of life-threatening listeria linked to Blue Bell ice cream products. Read more...

TOPICS:

Abbvie Raises Outlook as Humira Again Delivers Earnings Beat

April 23, 2015 1:36 pm | by Matthew Perrone, AP Health Writer | News | Comments

Drugmaker AbbVie is raising its full-year earnings guidance after reporting better-than-expected first quarter adjusted results on continued growth of its blockbuster anti-inflammatory drug Humira. Read more...

TOPICS:

Pipeline Advancements, Asset Acquisitions Fueled Mid-Cap Biotech R&D Spend in 2014

April 23, 2015 12:22 pm | by Adam Dion, GlobalData's Senior Industry Analyst | Articles | Comments

The combined spend on research and development (R&D) for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a total of $9.7 billion in 2014. Read more...

TOPICS:

Roche Sales Up 3 Percent Amid Demand for Breast Cancer Drugs

April 23, 2015 9:15 am | by The Associated Press | News | Comments

Breast cancer drugs such as Herceptin as well as new uses for multi-cancer drug Avastin helped Swiss pharmaceutical firm Roche grow sales by 3 percent during the first quarter. Read more...

TOPICS:

Divestment Gains Boost Net Earnings at Novartis

April 23, 2015 9:11 am | by The Associated Press | News | Comments

Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit Thursday as it recorded one-time gains from deals with other drug companies. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading